<code id='0E36F9678F'></code><style id='0E36F9678F'></style>
    • <acronym id='0E36F9678F'></acronym>
      <center id='0E36F9678F'><center id='0E36F9678F'><tfoot id='0E36F9678F'></tfoot></center><abbr id='0E36F9678F'><dir id='0E36F9678F'><tfoot id='0E36F9678F'></tfoot><noframes id='0E36F9678F'>

    • <optgroup id='0E36F9678F'><strike id='0E36F9678F'><sup id='0E36F9678F'></sup></strike><code id='0E36F9678F'></code></optgroup>
        1. <b id='0E36F9678F'><label id='0E36F9678F'><select id='0E36F9678F'><dt id='0E36F9678F'><span id='0E36F9678F'></span></dt></select></label></b><u id='0E36F9678F'></u>
          <i id='0E36F9678F'><strike id='0E36F9678F'><tt id='0E36F9678F'><pre id='0E36F9678F'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:71716
          Adobe

          Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

          Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

          advertisement

          The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene
          Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

          1:35PoliceblocktherentalhomewherefourUniversityofIdahostudentswerestabbedtodeathinNovember2022,inMos

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

          1:35VIDEO:Catchuponthedevelopingstoriesmakingheadlines.STOCKIMAGE/GettyImagesAFordassemblyplantinCla